-transparent.png){kind=logo}
Benz(a)anthracene (BA) and its five possible trans-dihydrodiols were evaluated for determination of their skin tumor-initiating activity and their mutagenic activity in Chinese hamster V79 cells. In addition, the skin tumor-initiating abilities of five diol-epoxides of BA were tested. Results showed (+/-)-trans-3,4-dihydroxy-3,4-dihydrobenz(a)anthracene (BA 3,4-dihydrodiol) to be approximately 10 times more mutagenic than was BA and about 20 times more mutagenic than were the other possible dihydrodiols in the V79 cells cocultivated with irradiated hamster embryo cells. As a skin tumor initiator, BA 3,4-dihydrodiol was approximately 5 times more active than BA, whereas the other BA dihydrodiols were all less active tumor initiators. (+/-)-trans-3alpha,4beta-Dihydroxy-1alpha,2alpha-epoxy-1,2,3,4-tetrahydrobenz(a)anthracene was found to be approximately 20% more active as a tumor initiator than was BA 3,4-dihydrodiol, whereas the other diol-epoxides of BA were less active than BA itself. The results suggest that the bay-region diol-epoxide of BA may be the ultimate carcinogen and mutagenic form of BA.
T J Slaga, and
E Huberman, and
J K Selkirk, and
R G Harvey, and
W M Bracken
September 1975,
Biochemical and biophysical research communications,
T J Slaga, and
E Huberman, and
J K Selkirk, and
R G Harvey, and
W M Bracken
July 1977,
Proceedings of the National Academy of Sciences of the United States of America,
T J Slaga, and
E Huberman, and
J K Selkirk, and
R G Harvey, and
W M Bracken
May 1995,
Steroids,
T J Slaga, and
E Huberman, and
J K Selkirk, and
R G Harvey, and
W M Bracken
December 1983,
Cancer research,
T J Slaga, and
E Huberman, and
J K Selkirk, and
R G Harvey, and
W M Bracken
July 1977,
Journal of toxicology and environmental health,
T J Slaga, and
E Huberman, and
J K Selkirk, and
R G Harvey, and
W M Bracken
February 1985,
The Journal of biological chemistry,
T J Slaga, and
E Huberman, and
J K Selkirk, and
R G Harvey, and
W M Bracken
July 1979,
Journal of the National Cancer Institute,
T J Slaga, and
E Huberman, and
J K Selkirk, and
R G Harvey, and
W M Bracken
April 1983,
Cancer research,
T J Slaga, and
E Huberman, and
J K Selkirk, and
R G Harvey, and
W M Bracken
September 1977,
Mutation research,
T J Slaga, and
E Huberman, and
J K Selkirk, and
R G Harvey, and
W M Bracken
March 1967,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
